For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Amortization of intangible assets | 57,344 | |||
| Research and development expenses | 4,269,479 | |||
| General and administrative expenses | 1,935,482 | |||
| Total operating expenses | 6,262,305 | |||
| Loss from operations | -6,262,305 | |||
| Interest expense | 5,967 | |||
| Interest income | 198,797 | |||
| Total other income, net | 192,830 | |||
| Net loss | -6,069,475 | |||
| Basic EPS | -0.77 | |||
| Diluted EPS | -0.77 | |||
| Basic Average Shares | 7,920,795 | |||
| Diluted Average Shares | 7,920,795 | |||
BIOVIE INC. (BIVIW)
BIOVIE INC. (BIVIW)